Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma

Chin Med J (Engl). 2023 Nov 5;136(21):2641-2643. doi: 10.1097/CM9.0000000000002599.
No abstract available

MeSH terms

  • Biomarkers, Tumor
  • Humans
  • Immunotherapy
  • Melanoma* / genetics
  • Melanoma* / therapy
  • Melanoma, Cutaneous Malignant
  • Methylation
  • Prognosis
  • RNA
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / therapy

Substances

  • RNA
  • Biomarkers, Tumor